These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 28579164)

  • 101. Bioresorbable everolimus-eluting vascular scaffold in patients with ST-segment elevation myocardial infarction: Optical coherence tomography evaluation and clinical outcomes.
    Kochman J; Tomaniak M; Pietrasik A; Kołtowski Ł; Rdzanek A; Huczek Z; Mazurek T; Jąkała J; Ząbek A; Legutko J; Kochman W; Filipiak KJ
    Cardiol J; 2015; 22(3):315-22. PubMed ID: 25428734
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Everolimus- vs. novolimus-eluting bioresorbable scaffolds in patients with acute coronary syndrome.
    Nef HM; Wiebe J; Schmidt G; Möllmann H; Boeder NF; Dörr O; Bauer T; Blachutzik F; Liebetrau C; Elsässer A; Foin N; Hamm CW
    Herz; 2020 Dec; 45(Suppl 1):95-104. PubMed ID: 31209520
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Serial 3-Dimensional Optical Coherence Tomography Assessment of Jailed Side-Branch by Second-Generation Drug-Eluting Absorbable Metal Scaffold (from the BIOSOLVE-II Trial).
    Ozaki Y; Garcia-Garcia HM; Hideo-Kajita A; Kuku KO; Haude M; Ince H; Abizaid A; Tölg R; Lemos PA; von Birgelen C; Christiansen EH; Wijns W; Escaned J; Waksman R
    Am J Cardiol; 2019 Apr; 123(7):1044-1051. PubMed ID: 30683424
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Is bioresorbable vascular scaffold acute recoil affected by baseline renal function and scaffold selection?
    Gunes HM; Yılmaz FK; Gokdeniz T; Demir GG; Guler E; Guler GB; Karaca O; Cakal B; İbişoğlu E; Boztosun B
    Int J Cardiol; 2016 Dec; 224():388-393. PubMed ID: 27681252
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial.
    Loffi M; Tousek P; Budesinsky T; Lisa L; Santangelo A; Widimsky P; Kocka V
    Heart Vessels; 2018 Nov; 33(11):1282-1287. PubMed ID: 29777297
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Serial assessment by optical coherence tomography of early and late vascular responses after implantation of an absorbable-coating Sirolimus-Eluting stent (from the first-in-human DESSOLVE I trial).
    Attizzani GF; Bezerra HG; Ormiston J; Wang W; Donohoe D; Wijns W; Costa MA
    Am J Cardiol; 2013 Nov; 112(10):1557-64. PubMed ID: 23992957
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Time course of vascular response after an a priori strategy of bare metal stent implantation post-dilated with a paclitaxel-coated balloon: Implementation of a three-dimensional analysis algorithm with optical coherence tomography.
    Otto S; Gassdorf J; Nitsche K; Gutiérrez-Chico JL; Kryvanos A; Goebel B; Figulla HR; Poerner TC
    Cardiol J; 2016; 23(3):296-306. PubMed ID: 27064798
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Bioresorbable scaffold -fourth revolution or failed revolution: Is low scaffold strut thickness the wrong target?
    Mishra S
    Indian Heart J; 2017; 69(6):687-689. PubMed ID: 29174242
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Early coverage of drug-eluting stents analysed by optical coherence tomography: evidence of the impact of stent apposition and strut characteristics on the neointimal healing process.
    Lee R; Foin N; Ng J; Allen J; Soh N; Ang I; Shim W; Torii R; Wong P
    EuroIntervention; 2016 Aug; 12(5):e605-14. PubMed ID: 27497360
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Investigating the Equivalent Plastic Strain in a Variable Ring Length and Strut Width Thin-Strut Bioresorbable Scaffold.
    Hoddy B; Ahmed N; Al-Lamee K; Bullett N; Curzen N; Bressloff NW
    Cardiovasc Eng Technol; 2022 Dec; 13(6):899-914. PubMed ID: 35819580
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Ex vivo assessment of neointimal characteristics after drug-eluting stent implantation: Optical coherence tomography and histopathology validation study.
    Imanaka T; Fujii K; Hao H; Shibuya M; Saita T; Kawakami R; Fukunaga M; Kawai K; Tamaru H; Miki K; Horimatsu T; Sumiyoshi A; Nishimura M; Hirota S; Masuyama T; Ishihara M
    Int J Cardiol; 2016 Oct; 221():1043-7. PubMed ID: 27447812
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Usefulness of Frequency Domain Optical Coherence Tomography Compared with Intravascular Ultrasound as a Guidance for Percutaneous Coronary Intervention.
    Kim IC; Yoon HJ; Shin ES; Kim MS; Park J; Cho YK; Park HS; Kim H; Nam CW; Han SW; Kim YN; Kim KB; Hur SH
    J Interv Cardiol; 2016 Apr; 29(2):216-24. PubMed ID: 26927366
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Automatic segmentation of optical coherence tomography pullbacks of coronary arteries treated with bioresorbable vascular scaffolds: Application to hemodynamics modeling.
    Bologna M; Migliori S; Montin E; Rampat R; Dubini G; Migliavacca F; Mainardi L; Chiastra C
    PLoS One; 2019; 14(3):e0213603. PubMed ID: 30870477
    [TBL] [Abstract][Full Text] [Related]  

  • 114. First in human evaluation of the vascular biocompatibility and biomechanical performance of a novel ultra high molecular weight amorphous PLLA bioresorbable scaffold in the absence of anti-proliferative drugs: Two-year imaging results in humans.
    Moncada M; Delgado JA; Colombo A; Gasior P; Ramzipoor K; Estrada A; Lee C; Dokko D; Granada JF
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):E246-E253. PubMed ID: 29243353
    [TBL] [Abstract][Full Text] [Related]  

  • 115. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold?
    Sotomi Y; Onuma Y; Suwannasom P; Tateishi H; Tenekecioglu E; Zeng Y; Cavalcante R; Jonker H; Dijkstra J; Foin N; Koon JN; Collet C; de Winter RJ; Wykrzykowska JJ; Stone GW; Popma JJ; Kozuma K; Tanabe K; Serruys PW; Kimura T
    EuroIntervention; 2016 Oct; 12(8):e998-e1008. PubMed ID: 27721215
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Prevalence of parameters of suboptimal scaffold deployment following angiographic guided bioresorbable vascular scaffold implantation in real world practice - an optical coherence tomography analysis.
    Subban V; Sengottuvelu G; Uthayakumaran K; Rajendran R; Janakiraman E; Pakshirajan B; Thenpally JG; Kalidoss L; Victor SM; Kalarickal MS; Ajit MS
    Int J Cardiol; 2016 Oct; 220():32-42. PubMed ID: 27372040
    [TBL] [Abstract][Full Text] [Related]  

  • 118. An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8/Xpedition).
    Ormiston JA; Webber B; Ubod B; Darremont O; Webster MW
    EuroIntervention; 2015 May; 11(1):60-7. PubMed ID: 25680225
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Head-to-head comparison of a drug-free early programmed dismantling polylactic acid bioresorbable scaffold and a metallic stent in the porcine coronary artery: six-month angiography and optical coherence tomographic follow-up study.
    Durand E; Sharkawi T; Leclerc G; Raveleau M; van der Leest M; Vert M; Lafont A
    Circ Cardiovasc Interv; 2014 Feb; 7(1):70-9. PubMed ID: 24368820
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.